Liang Jin Selected Research

neurexophilin

1/2022

Neurexophilin 4 is a prognostic biomarker correlated with immune infiltration in bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Jin Research Topics

Disease

44	Neoplasms (Cancer) 01/2022 - 10/2004
31	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2009
17	Inflammation (Inflammations) 11/2021 - 02/2011
16	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 01/2008
15	Neoplasm Metastasis (Metastasis) 07/2022 - 05/2012
10	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 12/2011
9	Carcinoma (Carcinomatosis) 01/2022 - 10/2004
9	Infections 01/2022 - 07/2012
8	Body Weight (Weight, Body) 06/2021 - 10/2009
8	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2012
8	Autoimmune Diseases (Autoimmune Disease) 10/2017 - 01/2009
6	Insulin Resistance 01/2022 - 12/2017
6	Hyperglycemia 11/2021 - 01/2014
6	Alzheimer Disease (Alzheimer's Disease) 10/2021 - 01/2016
5	Obesity 07/2022 - 12/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 01/2018
4	Melanoma (Melanoma, Malignant) 07/2022 - 07/2009
4	Carcinogenesis 01/2022 - 01/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2019
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 02/2015
4	Lung Neoplasms (Lung Cancer) 06/2019 - 01/2017
4	Atherosclerosis 10/2018 - 06/2009
3	Adenocarcinoma 01/2022 - 01/2019
3	Necrosis 01/2022 - 05/2015
3	Hypoxia (Hypoxemia) 01/2022 - 09/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
3	Hyperplasia 11/2019 - 01/2016
3	Fibrosis (Cirrhosis) 01/2018 - 12/2017
3	Bullous Pemphigoid (Pemphigoid) 01/2018 - 01/2013
3	Insulinoma 10/2017 - 06/2016
2	Neuroinflammatory Diseases 01/2022 - 05/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2022
2	Disease Progression 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
18	Peptides (Polypeptides)IBA 01/2022 - 01/2008
11	Long Noncoding RNAIBA 07/2022 - 06/2018
9	Insulin (Novolin)FDA Link 11/2021 - 01/2014
8	CytokinesIBA 01/2019 - 12/2011
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2017
7	VaccinesIBA 01/2019 - 01/2008
6	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2012
6	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
6	Streptozocin (Streptozotocin)FDA Link 11/2021 - 05/2015
6	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2010
6	Estrogen ReceptorsIBA 01/2020 - 02/2009
6	EpitopesIBA 10/2017 - 04/2008
6	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2016 - 04/2008
5	LipidsIBA 07/2022 - 06/2009
5	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 02/2009
5	AutoantibodiesIBA 10/2018 - 09/2009
5	AntibodiesIBA 01/2013 - 07/2009
4	LipopolysaccharidesIBA 01/2022 - 02/2011
4	CateninsIBA 01/2022 - 11/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 05/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 10/2006
4	AutoantigensIBA 01/2017 - 01/2009
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2016
3	ElementsIBA 01/2022 - 10/2004
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2020
3	Biological ProductsIBA 08/2021 - 03/2019
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2017
3	Tamoxifen FDA LinkGeneric 11/2020 - 05/2012
3	Epidermal Growth Factor (EGF)IBA 01/2020 - 01/2017
3	PolymersIBA 11/2019 - 01/2017
3	Protein Kinases (Protein Kinase)IBA 10/2019 - 01/2018
3	FlavonoidsIBA 03/2019 - 03/2011
3	Hormones (Hormone)IBA 01/2019 - 12/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 04/2012
3	Keratin-17 (Keratin 17)IBA 12/2018 - 03/2014
3	CholesterolIBA 10/2018 - 06/2009
3	AntigensIBA 01/2018 - 06/2011
3	Chaperonin 60IBA 10/2017 - 06/2016
3	Colistin (Coly-Mycin)FDA Link 10/2012 - 10/2009
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2012 - 02/2009
3	DNA VaccinesIBA 12/2009 - 07/2009
3	Gastrin-Releasing PeptideIBA 12/2009 - 07/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2016
2	MagnesiumIBA 08/2021 - 01/2019
2	Everolimus FDA Link 07/2021 - 06/2018
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2021 - 01/2016
2	InterferonsIBA 09/2020 - 01/2016

Therapy/Procedure

30	Therapeutics 01/2022 - 03/2011
11	Drug Therapy (Chemotherapy) 01/2022 - 06/2011
9	Immunotherapy 05/2021 - 01/2009
5	Segmental Mastectomy (Lumpectomy) 01/2022 - 12/2011
5	Radiotherapy 01/2022 - 01/2014
5	Neoadjuvant Therapy 01/2020 - 12/2011
3	Esophagectomy 04/2020 - 01/2018
3	Glycemic Control 01/2018 - 02/2015
2	Oral Administration 07/2022 - 01/2016
2	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 01/2019